Fingerprint
Dive into the research topics of 'TTP399: an investigational liver-selective glucokinase (GK) activator as a potential treatment for type 2 diabetes'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
TTP399: an investigational liver-selective glucokinase (GK) activator as a potential treatment for type 2 diabetes
Aoife Egan, Adrian Vella
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations